Form 4: Stoke Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Edward M. Kaye, a Director of Stoke Therapeutics, Inc., sold 12,567 shares of common stock on August 14, 2026.
Summary
- Option exercise/conversion: acquired 26,250 Common Stock on August 14, 2026; holds 137,124 after (Direct).
- Open-market sale: disposed of 11,930 Common Stock at $32.01 ($381,846) on August 18, 2026; holds 125,194 after (Direct).
- Open-market sale: disposed of 637 Common Stock at $32.47 ($20,682) on August 18, 2026; holds 124,557 after (Direct).
- Option exercise/conversion: disposed of 26,250 Performance Stock Units on August 14, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $402,528 of stock on the open market.
Insider Transactions
Edward M. Kaye — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Option exercise/conversion | Common Stock | 26,250 | — | — | 137,124 |
| 2026-08-18 | Open-market sale | Common Stock | 11,930 | $32 | $381.8K | 125,194 |
| 2026-08-18 | Open-market sale | Common Stock | 637 | $32 | $20.7K | 124,557 |
| 2026-08-14 | Option exercise/conversion | Performance Stock Units | 26,250 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Option exercise/conversion (26,250 shares) |
| 2026-08-18 | Open-market sale (11,930 shares) |
| 2026-08-18 | Open-market sale (637 shares) |
| 2026-08-14 | Option exercise/conversion (26,250 shares) |
Keywords
insider transaction, Form 4, STOK, Stoke Therapeutics, Inc., bearish, Edward M. Kaye
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.